Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	27.12	108.90	85.67
Graham Fair Price	15.81	4749.71	4101.34
PEG	125.18	1.66	0.74
Price/Book	37.52	10.19	7.41
Price/Cash Flow	-63.67	153.61	422.85
Prices/Earnings	24.69	35.89	28.78
Price/Sales	29.99	32.77	25.21
Price/FCF	-63.67	153.61	422.85
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-2.31	0.47	0.48
Operating Margin	-7.12	0.27	0.29
ROA	11.08	0.05	0.05
ROE	0.06	0.07	10.29
ROIC	0.08	0.07	-17.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.36	< 0.005	7031.43
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.38	0.10	-74.49
EPS QOQ	0.39	0.22	-44.63
FCF QOQ	0.10	3.22	3218.42
Revenue QOQ	0.08	0.18	115.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	289.89	235.82	-18.65
Days Sales Outstanding (DSO)	65.04	64.31	-1.12
Inventory Turnover	0.31	0.38	22.93
Debt/Capitalization	-0.25	< 0.005	-98.94
Quick Ratio	1.23	1.41	14.35
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3408.26	3758.42	10.27
Cash	761.32	1009.01	32.53
Capex	0.00	-47.57	-100.00
Free Cash Flow	59.73	249.34	317.47
Revenue	1001.69	1168.61	16.66
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.76	2.78	0.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.42	-2.79	-15.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating